AI Convergence: Small Molecule Discovery Summit

With the fast-evolving nature of AI/ML tool development for small molecule discovery, staying ahead of the curve has become increasingly difficult. The AI Convergence: Small Molecule Discovery Summit is your chance to respond to this industry moment head-on.

Unite with industry leaders such as Insilico Medicine, Psivant Therapeutics, Sanofi, Novo Nordisk, as well as newcomers including Eli Lilly’s TuneLab, Expedition Medicines and Montai Therapeutics.

Featuring applied talks that provide confidence on small molecule discovery innovation from concept to IND, alongside proven wet lab validation and increased probability of success, walk away feeling empowered to advance better, AI-enabled small molecules to patients faster.